Nph insulin conversion to lantus

Size: px
Start display at page:

Download "Nph insulin conversion to lantus"

Transcription

1 Nph insulin conversion to lantus Search RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus ( insulin glargine [rdna origin KEY POINTS. Whether to start insulin therapy and which regimen to use depend on a number of factors, including the patient s acceptance and willingness. work; Duration of action - length of time after injection that insulin will. Long-Acting Insulin's, Insulin Detemir, Levemir, Insulin Glargine, Lantus. Lantus and Levemir have a variety of things in common and are often confused with one another. Both are basal insulin equations, which implies that they keep going. Illustration of the semilente and ultralente insulin activity of Caninsulin /Vetsulin. This is not exclusive to the insulin ; all Lente insulins contain 30% amorphous. Detailed Insulin Glargine dosage information for adults, the elderly and TEENren. Includes dosages for Diabetes Type 2 and Diabetes Type 1; plus renal, liver and. Review of insulin dosing, adjusting basal and premeal insulin, carbohydrate counting and insulin, exercise and insulin, converting doses of insulin between brands. Insulin is used as a medication to treat high blood sugar. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and. Calculates morning and night time insulin dose based on weight in pounds. The conversion factor requires clinical judgement depending on the type of diabetes, body. Jun 16, The regular insulin will be dosed in the hospital per sliding scale with either regular insulin or a rapid-acting insulin such as Lispro. To convert the NPH dose to Lantus, the dose can be reduced by approximately 20% to (approximately) 20 units, especially if the patient has been well controlled previously at. Important Notes:. Be sure to discontinue IV insulin infusion 60 minutes after the first doses of SQ insulin if both insulin glargine. (Lantus) and either rapid-acting or regular insulin is given. Discontinue IV insulin 4 hours after insulin if just insulin glargine (Lantus) is given. (Therefore it is best to transition the patient at a meal. Lantus, on the other hand, has an onset of two hours and then continues at the same level (with no peak) for up to 24 hours. Most people on NPH require two daily injections, while Lantus users typically need only one injection per day (not counting injections of other, shorter-acting insulin they may need). Still, with careful. Converting from other insulin therapies may require adjustment of timing and dose of Lantus ; Closely monitor glucose values, especially upon converting to Lantus and during the initial weeks thereafter; Dosage adjustments may be needed with changes in physical activity, changes in meal patterns, during acute illness,. A 45 yo female with Type 1 DM takes 8 units of SQ glargine(lantus) each morning. (She takes mealtime short-acting insulin as well). She is admitted to the hospital for volume overload in the setting of ESRD. Her medication record reflects the plan for her to receive 8 units glargine(lantus) at 0800 each morning. Insulins include afrezza, apidra, basaglar, humalog, humulin, lantus, levemir, tresiba, ryzodeg, toujeo, novolin, and novolog. before use (see instructions with product); Humulin N should appear uniformly cloudy with no particulate matter after mixing; Information on converting between NPH and other insulins - Click here. Glargine (Lantus ). Detemir (Levemir ). Intermediate-acting: NPH Note: NPH insulin has elevated

2 risk of hypoglycemia so use with extra caution6,8,15,17,25, 32.. Basal insulin is best starting insulin choice for most patients (if fasting glucose above goal). 6,7,8.. Start one of the intermediate-acting or long-acting insulins. Calculates morning and night time insulin dose based on weight in pounds. The conversion factor requires clinical judgement depending on the type of diabetes, body weight, and insulin resistance. The conversion factor can range from 0.3 to 0.8 units of insulin per kilogram. Also calculates daily insulin glargine, ie Lantus,. The Basal/Nutritional/Correctional Insulin Concept x Basal insulin: 40-50% of Total Daily Dose (TDD) insulin z Long acting insulin required in all Type 1 and most Type 2 patients even when NPO. (gluconeogenesis can serve as a continuous source of blood glucose) z Takes care of the minute to minute need for insulin. Calculates morning and night time insulin dose based on weight in pounds. The Lantus and Levemir have a variety of things in common and are often confused with one another. Both are basal insulin equations, which implies that they keep going. Review of insulin dosing, adjusting basal and premeal insulin, carbohydrate counting and insulin, exercise and insulin, converting doses of insulin between brands. RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus (insulin glargine [rdna origin] injection. work; Duration of action - length of time after injection that insulin will. Detailed Insulin Glargine dosage information for adults, the elderly and TEENren. Includes dosages for Diabetes Type 2 and Diabetes Type 1; plus renal, liver and. Insulin is used as a medication to treat high blood sugar. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and. Long-Acting Insulin's, Insulin Detemir, Levemir, Insulin Glargine, Lantus. Illustration of the semilente and ultralente insulin activity of Caninsulin/Vetsulin. This is not exclusive to the insulin; all Lente insulins contain 30% amorphous. ABSTRACTIn type 2 diabetes mellitus, oral hypoglycemic agents and analogues of glucagon-like peptide-1 provide adequate glycemic control early in the disease. Insulin. Illustration of the semilente and ultralente insulin activity of Caninsulin /Vetsulin. This is not exclusive to the insulin ; all Lente insulins contain 30% amorphous. work; Duration of action - length of time after injection that insulin will. Lantus and Levemir have a variety of things in common and are often confused with one another. Both are basal insulin equations, which implies that they keep going. Detailed Insulin Glargine dosage information for adults, the elderly and TEENren. Includes dosages for Diabetes Type 2 and Diabetes Type 1; plus renal, liver and. Long-Acting Insulin's, Insulin Detemir, Levemir, Insulin Glargine, Lantus. Insulin is used as a medication to treat high blood sugar. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and KEY POINTS. Whether to start insulin therapy and which regimen to use depend on a number of factors, including the patient s acceptance and willingness. Review of insulin dosing, adjusting basal and premeal insulin, carbohydrate counting and insulin, exercise and insulin, converting doses of insulin between brands RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus ( insulin glargine [rdna origin. Calculates morning and night time insulin dose based on weight in pounds. The A 45 yo female with Type 1 DM takes 8 units of SQ glargine(lantus) each morning. (She takes mealtime short-acting insulin as well). She is admitted to the hospital for volume

3 overload in the setting of ESRD. Her medication record reflects the plan for her to receive 8 units glargine(lantus) at 0800 each morning. Glargine (Lantus ). Detemir (Levemir ). Intermediate-acting: NPH Note: NPH insulin has elevated risk of hypoglycemia so use with extra caution6,8,15,17,25, 32.. Basal insulin is best starting insulin choice for most patients (if fasting glucose above goal). 6,7,8.. Start one of the intermediate-acting or long-acting insulins. Insulins include afrezza, apidra, basaglar, humalog, humulin, lantus, levemir, tresiba, ryzodeg, toujeo, novolin, and novolog. before use (see instructions with product); Humulin N should appear uniformly cloudy with no particulate matter after mixing; Information on converting between NPH and other insulins - Click here. Important Notes:. Be sure to discontinue IV insulin infusion 60 minutes after the first doses of SQ insulin if both insulin glargine. (Lantus) and either rapid-acting or regular insulin is given. Discontinue IV insulin 4 hours after insulin if just insulin glargine (Lantus) is given. (Therefore it is best to transition the patient at a meal. Lantus, on the other hand, has an onset of two hours and then continues at the same level (with no peak) for up to 24 hours. Most people on NPH require two daily injections, while Lantus users typically need only one injection per day (not counting injections of other, shorter-acting insulin they may need). Still, with careful. Jun 16, The regular insulin will be dosed in the hospital per sliding scale with either regular insulin or a rapid-acting insulin such as Lispro. To convert the NPH dose to Lantus, the dose can be reduced by approximately 20% to (approximately) 20 units, especially if the patient has been well controlled previously at. Converting from other insulin therapies may require adjustment of timing and dose of Lantus ; Closely monitor glucose values, especially upon converting to Lantus and during the initial weeks thereafter; Dosage adjustments may be needed with changes in physical activity, changes in meal patterns, during acute illness,. The Basal/Nutritional/Correctional Insulin Concept x Basal insulin: 40-50% of Total Daily Dose (TDD) insulin z Long acting insulin required in all Type 1 and most Type 2 patients even when NPO. (gluconeogenesis can serve as a continuous source of blood glucose) z Takes care of the minute to minute need for insulin. Calculates morning and night time insulin dose based on weight in pounds. The conversion factor requires clinical judgement depending on the type of diabetes, body weight, and insulin resistance. The conversion factor can range from 0.3 to 0.8 units of insulin per kilogram. Also calculates daily insulin glargine, ie Lantus,. Detailed Insulin Glargine dosage information for adults, the elderly and TEENren. Includes dosages for Diabetes Type 2 and Diabetes Type 1; plus renal, liver and. RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus (insulin glargine [rdna origin] injection. Calculates morning and night time insulin dose based on weight in pounds. The ABSTRACTIn type 2 diabetes mellitus, oral hypoglycemic agents and analogues of glucagon-like peptide-1 provide adequate glycemic control early in the disease. Insulin. Review of insulin dosing, adjusting basal and premeal insulin, carbohydrate counting and insulin, exercise and insulin, converting doses of insulin between brands. Insulin is used as a medication to treat high blood sugar. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and. PHARMACOKINETICS. Onset of action - time period after injection that insulin will begin to work; Duration of action - length of time after injection that insulin will. Lantus and Levemir have a variety of things in common and are often confused with one another. Both are basal insulin equations, which implies that they keep going. Illustration of the semilente and ultralente insulin activity of Caninsulin/Vetsulin. This is not exclusive to the insulin; all Lente insulins contain 30%

4 amorphous. Long-Acting Insulin's, Insulin Detemir, Levemir, Insulin Glargine, Lantus. Detailed Insulin Glargine dosage information for adults, the elderly and TEENren. Includes dosages for Diabetes Type 2 and Diabetes Type 1; plus renal, liver and. Illustration of the semilente and ultralente insulin activity of Caninsulin /Vetsulin. This is not exclusive to the insulin ; all Lente insulins contain 30% amorphous. Long-Acting Insulin's, Insulin Detemir, Levemir, Insulin Glargine, Lantus. Calculates morning and night time insulin dose based on weight in pounds. The conversion factor requires clinical judgement depending on the type of diabetes, body RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus ( insulin glargine [rdna origin. Insulin is used as a medication to treat high blood sugar. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and. Lantus and Levemir have a variety of things in common and are often confused with one another. Both are basal insulin equations, which implies that they keep going. Review of insulin dosing, adjusting basal and premeal insulin, carbohydrate counting and insulin, exercise and insulin, converting doses of insulin between brands KEY POINTS. Whether to start insulin therapy and which regimen to use depend on a number of factors, including the patient s acceptance and willingness. PHARMACOKINETICS. Onset of action - time period after injection that insulin will begin to work; Duration of action - length of time after injection that insulin will. Insulins include afrezza, apidra, basaglar, humalog, humulin, lantus, levemir, tresiba, ryzodeg, toujeo, novolin, and novolog. before use (see instructions with product); Humulin N should appear uniformly cloudy with no particulate matter after mixing; Information on converting between NPH and other insulins - Click here. The Basal/Nutritional/Correctional Insulin Concept x Basal insulin: 40-50% of Total Daily Dose (TDD) insulin z Long acting insulin required in all Type 1 and most Type 2 patients even when NPO. (gluconeogenesis can serve as a continuous source of blood glucose) z Takes care of the minute to minute need for insulin. Calculates morning and night time insulin dose based on weight in pounds. The conversion factor requires clinical judgement depending on the type of diabetes, body weight, and insulin resistance. The conversion factor can range from 0.3 to 0.8 units of insulin per kilogram. Also calculates daily insulin glargine, ie Lantus,. Glargine (Lantus ). Detemir (Levemir ). Intermediate-acting: NPH Note: NPH insulin has elevated risk of hypoglycemia so use with extra caution6,8,15,17,25, 32.. Basal insulin is best starting insulin choice for most patients (if fasting glucose above goal). 6,7,8.. Start one of the intermediate-acting or long-acting insulins. Important Notes:. Be sure to discontinue IV insulin infusion 60 minutes after the first doses of SQ insulin if both insulin glargine. (Lantus) and either rapidacting or regular insulin is given. Discontinue IV insulin 4 hours after insulin if just insulin glargine (Lantus) is given. (Therefore it is best to transition the patient at a meal. Converting from other insulin therapies may require adjustment of timing and dose of Lantus ; Closely monitor glucose values, especially upon converting to Lantus and during the initial weeks thereafter; Dosage adjustments may be needed with changes in physical activity, changes in meal patterns, during acute illness,. A 45 yo female with Type 1 DM takes 8 units of SQ glargine(lantus) each morning. (She takes mealtime shortacting insulin as well). She is admitted to the hospital for volume overload in the setting of ESRD. Her medication record reflects the plan for her to receive 8 units glargine(lantus) at 0800 each morning. Lantus, on the other hand, has an onset of two hours and then continues at the same level (with no peak) for up to 24 hours. Most people on NPH require two daily injections, while Lantus users typically need only one injection per day (not counting injections of other, shorter-acting insulin they may need). Still, with

5 careful. Jun 16, The regular insulin will be dosed in the hospital per sliding scale with either regular insulin or a rapid-acting insulin such as Lispro. To convert the NPH dose to Lantus, the dose can be reduced by approximately 20% to (approximately) 20 units, especially if the patient has been well controlled previously at. work; Duration of action - length of time after injection that insulin will. Lantus and Levemir have a variety of things in common and are often confused with one another. Both are basal insulin equations, which implies that they keep going. Illustration of the semilente and ultralente insulin activity of Caninsulin/Vetsulin. This is not exclusive to the insulin; all Lente insulins contain 30% amorphous. Review of insulin dosing, adjusting basal and premeal insulin, carbohydrate counting and insulin, exercise and insulin, converting doses of insulin between brands. Calculates morning and night time insulin dose based on weight in pounds. The conversion factor requires clinical judgement depending on the type of diabetes, body. Detailed Insulin Glargine dosage information for adults, the elderly and TEENren. Includes dosages for Diabetes Type 2 and Diabetes Type 1; plus renal, liver and. ABSTRACTIn type 2 diabetes mellitus, oral hypoglycemic agents and analogues of glucagon-like peptide-1 provide adequate glycemic control early in the disease. Insulin. RESPONSE FROM AVENTIS. We appreciate the opportunity to respond to Dr. Grajower s request for information regarding Lantus (insulin glargine [rdna origin] injection. Long- Acting Insulin's, Insulin Detemir, Levemir, Insulin Glargine, Lantus. Insulin is used as a medication to treat high blood sugar. This includes in diabetes mellitus type 1, diabetes mellitus type 2, gestational diabetes, and. There are no recent pull requests.

Insulin conversion from nph to lantus

Insulin conversion from nph to lantus Insulin conversion from nph to lantus 07/29/2017 Lunesta and orange juice 07/30/2017 5th grade list of multisyllabic words 07/31/2017-8th grade yearbook message to son -Bellsouth email login my account

More information

Lantus levemir conversion

Lantus levemir conversion Lantus levemir conversion Search Learn about starting insulin-naïve patients with type 2 diabetes on Levemir. Read Important Safety & Prescribing Info on the HCP Website. Lantus and Levemir have a variety

More information

Lantus to levemir conversion

Lantus to levemir conversion Lantus to levemir conversion The Borg System is 100 % Lantus to levemir conversion 16-6-2005 Ask the Expert on... Lantus Conversion. Karen Shapiro, PharmD, BCPS. Disclosures. June 16, 2005. Question. Would

More information

Conversion from lantus to tresiba

Conversion from lantus to tresiba Conversion from lantus to tresiba Search dosages for Diabetes Type 2 and Diabetes Type 1; plus renal, liver and. Forecast your health care. Every time you have a symptom or are diagnosed of a condition,

More information

Degludec lantus conversion

Degludec lantus conversion Degludec lantus conversion Search embarazadas con elevado riesgo de enfermedad tiroidea usando la. There are various possible causes of a high blood sugar level in the morning: The Dawn Phenomenon which

More information

Converting lantus to humalog 75 25

Converting lantus to humalog 75 25 P ford residence southampton, ny Converting lantus to humalog 75 25 This page includes the following topics and synonyms: Insulin Dosing in Type 2 Diabetes, Insulin Dosing in Type II Diabetes. Thiazide

More information

Conversion of lantus to toujeo

Conversion of lantus to toujeo Conversion of lantus to toujeo Search The dosing information for Toujeo recommends decreasing the total insulin dose to 80% of the daily requirement of Toujeo when switching from to. Watch a video to learn

More information

Insulin Prior Authorization with optional Quantity Limit Program Summary

Insulin Prior Authorization with optional Quantity Limit Program Summary Insulin Prior Authorization with optional Quantity Limit Program Summary 1-13,16-19, 20 FDA LABELED INDICATIONS Rapid-Acting Insulins Humalog (insulin lispro) NovoLog (insulin aspart) Apidra (insulin glulisine)

More information

Toujeo conversion to lantus

Toujeo conversion to lantus Detailed dosage guidelines and administration information for Toujeo (insulin glargine). Includes dose adjustments, warnings. The TOUJEO SoloStar prefilled pen has been specifically designed for TOUJEO,

More information

Toujeo to lantus conversion

Toujeo to lantus conversion P ford residence southampton, ny Toujeo to lantus conversion Chart of all the available insulins and their properties including onset of action, duration of action, available forms (vials and pens), peak

More information

Insulin nph to levemir conversion

Insulin nph to levemir conversion Insulin nph to levemir conversion 08/31/2017 New star soccer unblocked 09/01/2017 Tiny bumps 09/02/2017 -The address to the publishers clearing house -Chudai ke time yoni ke ander Kay hota ha 09/04/2017

More information

Nph to lantus conversion chart

Nph to lantus conversion chart Nph to lantus conversion chart 01/28/2018 Prozac and paxil anorexia nervosa 01/30/2018 Hooking up amazon fire tv to receiver 02/01/2018 -Free gay chat lines in philly -Unblocked games 77 multilateadoll2

More information

Nph conversion to lantus insulin

Nph conversion to lantus insulin Nph 07/17/2017 Ativan dependency symptoms 07/19/2017 Bankruptcy services mail 07/21/2017-450 bushmaster vs 30-30 -Tussionex with codeine dosage 07/22/2017 Commercial electric ms8301a user manual Jun 16,

More information

What is shelf life of lantus

What is shelf life of lantus What is shelf life of lantus Search 6-6-2011 I've been told Lantus looses some of it's effectiveness after 30. Levemir has a 42 day shelf life after opening. 5 Reasons to Join Diabetic Connect;. Lantus

More information

Conversion of lantus to insulin

Conversion of lantus to insulin Conversion of lantus to 70 30 insulin 11/27/2017 Tramadol overdose dosage 11/29/2017 Fedex express pay stub 11/30/2017 -Us bank visa gift card balance check -Can you take tramadol with suboxone and be

More information

Nph to levemir conversion

Nph to levemir conversion Nph to levemir conversion 11/15/2017 Can omeprazole be given at bedtime 11/17/2017 Roblox robux card pin numbers 2017 11/18/2017 -Rick steves wife died -Serviporno mama e hija 11/19/2017 Arkansas medicaid

More information

Nph to levemir conversion rate

Nph to levemir conversion rate Nph to levemir conversion rate 11/14/2017 PANTOPRAZOLE DURING BLOOD TRANFUSION 11/15/2017 Comment number 1 11/16/2017 -Download vidmate for desktop -App youtube red 11/17/2017 Briggs pants size chart 11/18/2017

More information

Convert nph to levemir

Convert nph to levemir Convert nph to levemir 08/31/2017 Nmci east webmail access 09/02/2017 Mary kay hostess packet hostess info 09/03/2017 -Free music downloads for mp3 players for teens -Bluelight snorting gabapentin 09/04/2017

More information

Conversion from victoza to lantus

Conversion from victoza to lantus Conversion from victoza to lantus 01/14/2018 7.5 gauge trains for sale on ebay 01/17/2018 Anr relationship definition 01/18/2018 -Gabapentin false positive drug screen -Xxxxvdeo icd 9 saal ki 01/20/2018

More information

Insulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology

Insulin Basics. Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Insulin Basics Bryan Primary Care Conference May 21, 2016 Shannon Wakeley MD Complete Endocrinology Disclosures Speakers Bureau for Sanofi, Astra Zeneca, Janssen, Boehringer-Ingelheim Objectives Discuss

More information

Insulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products

Insulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products Insulin Prior Authorization Criteria For Individuals Who Purchased BlueCare/KS Solutions/EPO Products FDA LABELED INDICATIONS 1-13,16-21 Rapid-Acting Indication Onset Peak Duration Insulins Admelog (insulin

More information

INSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min.

INSULIN OVERVIEW. Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro min. 3-5 hrs min. INSULIN OVERVIEW Type Brand Name Onset Peak Duration Role in glucose management Page Rapid-Acting lispro Humalog 15-30 min 30-90 min 3-5 hrs aspart glulisine Short-Acting Regular insulin NovoLog Apidra

More information

Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes

Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes Types of Insulin Rapid-acting insulin: lispro (Humalog), aspart (NovoRapid), glulisine (Apidra) Regular short-acting insulin: Humulin R, Novolin ge Toronto, Hypurin Regular Basal insulin: NPH (Humulin

More information

Insulin Prior Authorization Criteria For Individuals who Purchased BlueCare / KS Solutions products

Insulin Prior Authorization Criteria For Individuals who Purchased BlueCare / KS Solutions products Insulin Prior Authorization Criteria For Individuals who Purchased BlueCare / KS Solutions products FDA LABELED INDICATIONS 1-13,16-20 Rapid-Acting Indication Onset Peak Duration Insulins Fiasp (insulin

More information

Newer Insulins. Boca Raton Regional Hospital 15th Annual Internal Medicine Conference

Newer Insulins. Boca Raton Regional Hospital 15th Annual Internal Medicine Conference Newer Insulins Boca Raton Regional Hospital 15th Annual Internal Medicine Conference Luigi F. Meneghini, MD, MBA Professor of Internal Medicine, UT Southwestern Medical Center Executive Director, Global

More information

x Regular insulin has a 1:1 dose conversion to aspart, but will have a longer dosing frequency than aspart because of longer duration of action.

x Regular insulin has a 1:1 dose conversion to aspart, but will have a longer dosing frequency than aspart because of longer duration of action. x Regular insulin has a 1:1 dose conversion to aspart, but will have a longer dosing frequency than aspart because of longer duration of action. x Detemir has a 1:1 dose conversion to glargine. Converting

More information

Levemir conversion to nph

Levemir conversion to nph Levemir conversion to nph 08/21/2017 Team names for mortgage industry 08/21/2017 Low back pain with bloated belly 08/22/2017 -High school camel toe -Bonworth clothing catalog womens clothing 08/23/2017

More information

Drug Effectiveness Review Project Summary Report Long acting Insulins

Drug Effectiveness Review Project Summary Report Long acting Insulins Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Type I Type II Insulin Resistance

Type I Type II Insulin Resistance Insulin An aqueous hormonal solution made in the pancreas. Affects metabolism by allowing glucose to leave the blood and enter the body cells, preventing hyperglycemia. It is measured in units, e.g. 100

More information

Learning Objectives. Perioperative SWEET Success

Learning Objectives. Perioperative SWEET Success Perioperative SWEET Success PERIOPERATIVE SWEET SUCCESS PRESENTED BY: KENDRA MARTIN, RN, BSN, CDE JENNIFER SIMPSON, RN, BC-ADM, MSN, CNS Disclosure to Participants Notice of Requirements For Successful

More information

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery

Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia

More information

Drug Use Criteria: Exogenous Insulin Products

Drug Use Criteria: Exogenous Insulin Products Texas Vendor Program Use Criteria: Exogenous Products Publication History 1. Developed June 2017. Notes: Information on indications for use or diagnosis is assumed to be unavailable. All criteria may be

More information

Module 5. Understanding Insulin Therapy

Module 5. Understanding Insulin Therapy Module 5. Understanding Insulin Therapy EDUCATIONAL OBJECTIVES Upon completion of this activity, participants will be better able to: 1. Define the basic physiologic concept of basal-bolus insulin; 2.

More information

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI

Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols. Askiel Bruno, MD, MS Protocol PI Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial Treatment Protocols Askiel Bruno, MD, MS Protocol PI SHINE Synopsis Acute ischemic stroke

More information

Basal Bolus Insulin Therapy Frequently Asked Questions

Basal Bolus Insulin Therapy Frequently Asked Questions 1. What is Basal Bolus Insulin Therapy (BBIT)? 2. What evidence supports the use of subcutaneous Basal Bolus Insulin Therapy? 3. Does Basal Bolus Insulin Therapy apply to all patients? 4. What s wrong

More information

Levemir vs lantus dose conversion

Levemir vs lantus dose conversion Levemir vs lantus dose conversion The Borg System is 100 % Levemir vs lantus dose conversion Converting patients from insuline glargine U-100 to insulin detemir. Converting from insulin glargine U-100.

More information

Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins

Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins Recommended Insulin Products This guideline states the Gloucestershire Joint Formulary recommended, first choice insulin products. The intention is to support the choice of treatment for new patients,

More information

Objectives 2/13/2013. Figuring out the dose. Sub Optimal Glycemic Control: Moving to the Appropriate Treatment

Objectives 2/13/2013. Figuring out the dose. Sub Optimal Glycemic Control: Moving to the Appropriate Treatment Sub Optimal Glycemic Control: Moving to the Appropriate Treatment Judy Thomas, MSN, FNP-BC Holt and Walton, Rheumatology and Endocrinology Objectives Upon completion of this session you will be better

More information

8/13/2016. Insulin Basics. Rapid-Acting Insulin Analogs. Current Insulin Products and Pens. Basal Insulin Analogs. History of Insulin Therapy

8/13/2016. Insulin Basics. Rapid-Acting Insulin Analogs. Current Insulin Products and Pens. Basal Insulin Analogs. History of Insulin Therapy Insulin Basics Anabolic hormone involved in metabolism Following carbohydrate ingestion insulin release is stimulated Suppresses hepatic glucose production Stimulates peripheral glucose uptake Commercially-available

More information

Update on New Basal Insulins and Combinations: Starting, Titrating and Adding to Therapy

Update on New Basal Insulins and Combinations: Starting, Titrating and Adding to Therapy Update on New Basal Insulins and Combinations: Starting, Titrating and Adding to Therapy Jerry Meece, BPharm, CDE, FACA, FAADE Director of Clinical Services Plaza Pharmacy and Wellness Center Gainesville,

More information

Insulin Regimens: Hitting Glycemia Targets

Insulin Regimens: Hitting Glycemia Targets Insulin Regimens: Hitting Glycemia Targets Grant Kelley MD March 1 st, 2018 Faculty Disclosure: Financial relationships with commercial interests None Overview Mortality and Morbidity Insulin and Insulin

More information

Objectives. Navigating New Insulins. Disclosures. Diabetes: The Stats. Normal Insulin Release Individuals without diabetes. History of Insulin 5/23/17

Objectives. Navigating New Insulins. Disclosures. Diabetes: The Stats. Normal Insulin Release Individuals without diabetes. History of Insulin 5/23/17 Objectives Compare and contrast currently available products. Navigating New s Diana Isaacs, PharmD, BCPS, BC-ADM, CDE Clinical Pharmacy Specialist Cleveland Clinic Diabetes Center Determine the factors

More information

Tips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital

Tips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital Tips and Tricks for Starting and Adjusting Insulin MC MacSween The Moncton Hospital Progression of type 2 diabetes Beta cell apoptosis Natural History of Type 2 Diabetes The Burden of Treatment Failure

More information

These Aren t Your Average Rookies: A Primer on New and Emerging Insulins. Alissa R. Segal, Pharm.D, CDE, CDTC, FCCP

These Aren t Your Average Rookies: A Primer on New and Emerging Insulins. Alissa R. Segal, Pharm.D, CDE, CDTC, FCCP These Aren t Your Average Rookies: A Primer on New and Emerging Insulins Alissa R. Segal, Pharm.D, CDE, CDTC, FCCP Disclosures Eli Lilly & Company: Advisory board member Boehringer Ingelheim: Advisory

More information

Providing Stability to an Unstable Disease

Providing Stability to an Unstable Disease Basal Insulin Therapy Providing Stability to an Unstable Disease Thomas A. Hughes, M.D. Professor of Medicine - Retired Division of Endocrinology, Metabolism, and Diabetes University of Tennessee Health

More information

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University

In-Hospital Management of Diabetes. Dr Benjamin Schiff Assistant Professor McGill University In-Hospital Management of Diabetes Dr Benjamin Schiff Assistant Professor McGill University No conflict of interest to declare CLINICAL SCENARIO 62 y/o male with hx of DM 2, COPD, and HT is admitted with

More information

CANDY Camp Application

CANDY Camp Application CANDY Camp Application Please complete the following form and submit it by June 15, 2016. Please mail form to Bonnie Kruse, Diabetes Program Coordinator, HSHS St. Anthony s Memorial Hospital, 503 North

More information

Disclosure 1/16/2017. Michael R. Brennan D.O., M.S., F.A.C.E Director Beaumont Endocrine Center Chief of Endocrine Beaumont Grosse Pointe 1/16/2017 2

Disclosure 1/16/2017. Michael R. Brennan D.O., M.S., F.A.C.E Director Beaumont Endocrine Center Chief of Endocrine Beaumont Grosse Pointe 1/16/2017 2 Therapy For Diabetes Michigan Association of Osteopathic Family Physicians Mid-Winter Family Medicine Update Shanty Creek Resort, MI January 19-22nd 2017 Michael R. Brennan D.O., M.S., F.A.C.E Director

More information

Mixed Insulins Pick Me

Mixed Insulins Pick Me Mixed Insulins Pick Me Alvin Goo, PharmD Clinical Associate Professor University of Washington School of Pharmacy and Department of Family Medicine Objectives Critically evaluate the evidence comparing

More information

Adjusting Insulin Doses

Adjusting Insulin Doses Adjusting Insulin Doses Everyone with diabetes, including you, will need to adjust your insulin doses at some time. There are several reasons why a person may need an insulin adjustment. These reasons

More information

Premixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s

Premixed Insulin for Type 2 Diabetes. a gu i d e f o r a d u lt s Premixed Insulin for Type 2 Diabetes a gu i d e f o r a d u lt s March 2009 What This Guide Covers / 2 Type 2 Diabetes / 3 Learning About Blood Sugar / 4 Learning About Insulin / 5 Comparing Medicines

More information

Managing Diabetes when you are having a colonoscopy

Managing Diabetes when you are having a colonoscopy Managing Diabetes when you are having a colonoscopy Disclaimer This is general information developed by The Ottawa Hospital. It is not intended to replace the advice of a qualified health-care provider.

More information

Management of Diabetes New Concepts New Devices New Medications. Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth

Management of Diabetes New Concepts New Devices New Medications. Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth Management of Diabetes New Concepts New Devices New Medications Richard J. Comi, MD Professor of Medicine Geisel School of Medicine at Dartmouth Objectives: At the end of this lecture, the learner will

More information

Diabetes Mellitus in Small Animals

Diabetes Mellitus in Small Animals Diabetes Mellitus in Small Animals Julie A Stephens, DVM, DACVIM Veterinary Emergency And Specialty Center of New Mexico Albuquerque, New Mexico Diabetes Mellitus Persistent hyperglycemia caused by a relative

More information

INSULIN 101: When, How and What

INSULIN 101: When, How and What INSULIN 101: When, How and What Alice YY Cheng @AliceYYCheng Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted in any form

More information

8/21/2017 UNRAVELING THE CROWED INSULIN SCENE. A Practical Overview of Insulin Focusing on New Insulin Preparations

8/21/2017 UNRAVELING THE CROWED INSULIN SCENE. A Practical Overview of Insulin Focusing on New Insulin Preparations UNRAVELING THE CROWED INSULIN SCENE A Practical Overview of Insulin Focusing on New Insulin Preparations Patricia Garnica MS, ANP-BC, CDE, CDTC North Shore University Hospital, Manhasset, N.Y. October

More information

Diabetes in Pregnancy

Diabetes in Pregnancy Diabetes in Pregnancy Ebony Boyce Carter, MD, MPH Division of Maternal Fetal Medicine Washington University School of Medicine Disclosures I have no financial disclosures to report. Objectives Review the

More information

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia) How Medicine Works to Control Blood Sugar Levels Stacie Petersen, RN, CDE Objectives Define Diabetes List how medications work (ominous octet) Identify side effects of medications for diabetes What is

More information

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin Diabetes s Oral s - Pills These are some of the pills that are currently available in Canada to treat diabetes. Each medication has benefits and side effects you should be aware of. Your diabetes team

More information

Diabetes Head to Toe May 31, 2017

Diabetes Head to Toe May 31, 2017 Innovations in Insulin Joanne Reid RN CDE jmreid@gbhs.on.ca Danielle Benedict RPh Outline Setting the stage Insulin as pancreas replacement therapy Commonly used insulins New insulins Case Studies Dosing

More information

Insulins: Prices, Rebates, and Other Factors Influencing Costs. May 2018

Insulins: Prices, Rebates, and Other Factors Influencing Costs. May 2018 Insulins: Prices, Rebates, and Other Factors Influencing Costs May 2018 Introduction: Types of Insulin Types of Insulin Rapid-acting: Usually taken before a meal to cover the blood glucose elevation from

More information

AACN PCCN Review. Endocrine

AACN PCCN Review. Endocrine AACN PCCN Review Endocrine Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com Endocrine I. INTRODUCTION Disorders

More information

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE

INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE OBJECTIVES DESCRIBE INSULIN, INCLUDING WHERE IT COMES FROM AND WHAT IT DOES STATE THAT

More information

Basal Insulin Drug Class Prior Authorization Protocol

Basal Insulin Drug Class Prior Authorization Protocol Basal Insulin Drug Class Prior Authorization Protocol Line of Business: Medicaid P&T Approval Date: February 21, 2018 Effective Date: April 1, 2018 This policy has been developed through review of medical

More information

4/16/2018. Flexible Intensive Insulin Therapy (FIIT) in People with Type 2 Diabetes: A Viable Option. Disclosures. Outline. No financial disclosures

4/16/2018. Flexible Intensive Insulin Therapy (FIIT) in People with Type 2 Diabetes: A Viable Option. Disclosures. Outline. No financial disclosures Flexible Intensive Insulin Therapy (FIIT) in People with Type Diabetes: A Viable Option Kim Bisanz, MFCS, RDN, LDN, CDE Minnesota Academy of Nutrition & Dietetics Annual Meeting April 19, 18 18 MFMER slide-1

More information

Evidence for Basal Bolus Insulin Versus Slide Scale Insulin

Evidence for Basal Bolus Insulin Versus Slide Scale Insulin Curr Emerg Hosp Med Rep (2014) 2:26 34 DOI 10.1007/s40138-013-0032-4 DIABETES AND METABOLIC DISEASE (W FORD, SECTION EDITOR) Evidence for Basal Bolus Insulin Versus Slide Scale Insulin Sameer Badlani William

More information

Insulin Initiation and Intensification. Disclosure. Objectives

Insulin Initiation and Intensification. Disclosure. Objectives Insulin Initiation and Intensification Neil Skolnik, M.D. Associate Director Family Medicine Residency Program Abington Memorial Hospital Professor of Family and Community Medicine Temple University School

More information

Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices

Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices Authors: Jean Fuglesten Biniek William Johnson January 2019 Insulin Prices Were the Primary Driver of Rapid

More information

PET Cardiac Sarcoid Testing FDG only for People with Diabetes

PET Cardiac Sarcoid Testing FDG only for People with Diabetes PET Cardiac Sarcoid Testing FDG only for People with Diabetes What is a PET Cardiac Sarcoid Test FDG only? PET Cardiac Sarcoid Test takes a picture of your heart. This is done to find if any heart muscle

More information

Learning Objectives. Are you ready for more insulin formulations?

Learning Objectives. Are you ready for more insulin formulations? Are you ready for more insulin formulations? Shara Elrod, PharmD, BCACP, BCGP Learning Objectives Review pharmacology and dosing of new insulin formulations Compare and contrast new insulin formulations

More information

PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES

PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages

More information

Basal-Bolus Insulin Therapy. Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January

Basal-Bolus Insulin Therapy. Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January Basal-Bolus Insulin Therapy Veronica Brady, PhD, FNP-BC, BC-ADM, CDE ECHO January 18 2018 Terminology No longer using the term diabetic. Diabetes does not define people. People with diabetes are individuals

More information

Type 2 Diabetes Mellitus Insulin Therapy 2012

Type 2 Diabetes Mellitus Insulin Therapy 2012 Type 2 Diabetes Mellitus Therapy 2012 Michael T. McDermott MD Director, Endocrinology and Diabetes Practice University of Colorado Hospital Michael.mcdermott@ucdenver.edu Preparations Onset Peak Duration

More information

Initiating Injectable Therapy in Type 2 Diabetes

Initiating Injectable Therapy in Type 2 Diabetes Initiating Injectable Therapy in Type 2 Diabetes David Doriguzzi, PA C Learning Objectives To understand current Diabetes treatment guidelines To understand how injectable medications fit into current

More information

第十五章. Diabetes Mellitus

第十五章. Diabetes Mellitus Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances

More information

Guide for Storage of Insulin

Guide for Storage of Insulin Guide for Storage of Insulin Every effort is made to assure the accuracy of the attached information. This information is not intended to be used as a tool to prescribe medication or provide other clinical

More information

New Therapies for Diabetes Management: Hope or Headache?

New Therapies for Diabetes Management: Hope or Headache? New Therapies for Diabetes Management: Hope or Headache? Elizabeth Stephens, MD, FACP PMG- Endocrinology Elizabeth.Stephens@providence.org November 2018 Disclosures None 1 Objectives Discussion of 3 rd

More information

Diabetes: What You Need to Know

Diabetes: What You Need to Know UW MEDICINE PATIENT EDUCATION Diabetes: What You Need to Know Discharge review before you leave the hospital We want to be sure that we explained your diabetes instructions well, so that you know how to

More information

ClinicalTrials.gov Identifier: sanofi-aventis. Sponsor/company:

ClinicalTrials.gov Identifier: sanofi-aventis. Sponsor/company: These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: sanofi-aventis ClinicalTrials.gov

More information

New Drug Evaluation: Insulin degludec/aspart, subcutaneous injection

New Drug Evaluation: Insulin degludec/aspart, subcutaneous injection New Drug Evaluation: Insulin degludec/aspart, subcutaneous injection Date of Review: March 2016 End Date of Literature Search: November 11, 2015 Generic Name: Insulin degludec and insulin aspart Brand

More information

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors

Objectives. Recognize all available medical treatment options for diabetes. Individualize treatment and glycemic target based on patient factors No disclosure Objectives Recognize all available medical treatment options for diabetes Individualize treatment and glycemic target based on patient factors Should be able to switch to more affordable

More information

What s New in Type 2 Diabetes? 2018 Diabetes Updates

What s New in Type 2 Diabetes? 2018 Diabetes Updates What s New in Type 2 Diabetes? 2018 Diabetes Updates Gretchen Ray, PharmD, PhC, BCACP, CDE Associate Professor, UNM College of Pharmacy January 28, 2018 gray@salud.unm.edu OBJECTIVES Describe the most

More information

Insulin Basic facts. Patient Education Patient Care Services. What is insulin? What types of insulin are there? Basal Insulin

Insulin Basic facts. Patient Education Patient Care Services. What is insulin? What types of insulin are there? Basal Insulin Patient Education Insulin Basic facts Insulin is a protein made by the pancreas that allows your cells to use glucose for energy. There are different types of insulin: Basal long-acting insulin that controls

More information

ADMELOG, NOVOLIN, NOVOLOG, and FIASP

ADMELOG, NOVOLIN, NOVOLOG, and FIASP ADMELOG, NOVOLIN, NOVOLOG, and FIASP Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy

More information

MANAGEMENT OF TYPE 1 DIABETES MELLITUS

MANAGEMENT OF TYPE 1 DIABETES MELLITUS MANAGEMENT OF TYPE 1 DIABETES MELLITUS INVESTIGATIONS AND TREATMENT MANSI NAIK VII SEMESTER INVESTIGATIONS FASTING BLOOD SUGAR PLASMA GLUCOSE HEMOGLOBIN A 1c SYMPTOMS OF TYPE 1 DIABETES MELLITUS Polyuria

More information

Opinion 18 December 2013

Opinion 18 December 2013 The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 18 December 2013 LANTUS 100 units/ml, solution for injection in a vial B/1 vial of 10 ml (CIP: 34009 359 464 9 2)

More information

Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin

Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin Inpatient Diabetes Management: The Slippery Slope of Sliding Scale Insulin David Newman, MD University of North Dakota School of Medicine Sanford Health Big Sky Conference 2017 Dr. David Newman, Personal/Professional

More information

Comprehensive Diabetes Treatment

Comprehensive Diabetes Treatment Comprehensive Diabetes Treatment Joshua L. Cohen, M.D., F.A.C.P. Professor of Medicine Interim Director, Division of Endocrinology & Metabolism The George Washington University School of Medicine Diabetes

More information

Position Statement of ADA / EASD 2012

Position Statement of ADA / EASD 2012 Management of Hyperglycemia in Type2 Diabetes: A Patient- Centered Approach Position Statement of ADA / EASD 2012 Cause of : Type 2 diabetes Cardiovascular disorders Blindness End-stage renal failure Amputations

More information

2018 Diabetes Summit Managing Diabetes: An Art and a Science

2018 Diabetes Summit Managing Diabetes: An Art and a Science 2018 Diabetes Summit Managing Diabetes: An Art and a Science Natasha Petry, PharmD, BCACP NDSU College of Health Professions, School of Pharmacy, Department of Pharmacy Practice Patient-Centered Medical

More information

Antidiabetic Agents CHAPTER BIGUANIDES

Antidiabetic Agents CHAPTER BIGUANIDES ajt/shutterstock, Inc. CHAPTER 2 Antidiabetic Agents Charles Ruchalski, PharmD, BCPS BIGUANIDES For newly diagnosed patients with type 2 diabetes, the biguanide metformin is the drug of choice for initial

More information

Diabetes Update 10/12/2017. Section #1 OBJECTIVE. Lab features to consider:

Diabetes Update 10/12/2017. Section #1 OBJECTIVE. Lab features to consider: Section #1 OBJECTIVE Diabetes Update Fall 2017 Lyle Myers BE ABLE TO DIFFERENTIATE TYPE 1 FROM TYPE 2 DIABETES Clinical features: - age at onset - body weight/bmi - family history - treatment history -

More information

In-hospital management of diabetes

In-hospital management of diabetes Dr. Tom Elliott MBBS, FRCPC Medical Director 400-210 W Broadway phone: 604.683.3734 Vancouver, BC fax: 604.628.3821 V5Y 3W2 Canada email: moa@bcdiabetes.ca In-hospital management of diabetes General Management

More information

Initiation and Titration of Insulin in Diabetes Mellitus Type 2

Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Initiation and Titration of Insulin in Diabetes Mellitus Type 2 Greg Doelle MD, MS April 6, 2016 Disclosure I have no actual or potential conflicts of interest in relation to the content of this lecture.

More information

SCHOOL HEALTH PLAN: DIABETES

SCHOOL HEALTH PLAN: DIABETES BRANDON FLORENCE MCLAURIN NORTHWEST PELAHATCHIE RANKIN COUNTY SCHOOL DISTRICT GREAT TO BEST PISGAH PUCKETT RICHLAND RANKIN COUNTY SCHOOL DISTRICT SCHOOL HEALTH PLAN: DIABETES of Plan: Effective s: This

More information

PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES

PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES PHARMACISTS INTERACTIVE EDUCATION CASE STUDIES Disclaimer: The information in this document is not a substitute for clinical judgment in the care of a particular patient. CADTH is not liable for any damages

More information

OTE HAR M A. Insulin degludec (Tresiba ): Ultralong. basal insulin with less nocturnal hypoglycemia than glargine.

OTE HAR M A. Insulin degludec (Tresiba ): Ultralong. basal insulin with less nocturnal hypoglycemia than glargine. HAR M A Vol. 31, Issue 5 February 2016 N OTE Established 1985 Insulin degludec (Tresiba ): Ultra-long basal insulin with less nocturnal hypoglycemia than glargine Brian Nocito, PharmD Candidate D iabetes

More information

The principles of insulin adjustment guidance

The principles of insulin adjustment guidance The principles of insulin adjustment guidance Tips for insulin titration Blood glucose (BG) monitoring is needed to help identify the efficacy of treatment in diabetes. Monitor blood glucose according

More information

Reviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate

Reviewing Diabetes Guidelines. Newsletter compiled by Danny Jaek, Pharm.D. Candidate Reviewing Diabetes Guidelines Newsletter compiled by Danny Jaek, Pharm.D. Candidate AL AS KA N AT IV E DI AB ET ES TE A M Volume 6, Issue 1 Spring 2011 Dia bet es Dis pat ch There are nearly 24 million

More information

Pranay wal et al, /J. Pharm. Sci. & Res. Vol.2(5), 2010,

Pranay wal et al, /J. Pharm. Sci. & Res. Vol.2(5), 2010, Comparative efficacy of humalog mix 75/25 with human Insulin. Pranay wal 1 *, Ankita wal 2, Shivangi Srivastava 2,Abhinav srivastava 2, Umeshwar Pandey 3, Tarun Jain 1, Awani k Rai 2. 1 Jodhpur National

More information